| Summary: | 碩士 === 國立交通大學 === 管理學院高階主管管理碩士學程 === 106 === To reduce the financial burden from aging population, most government is committed to reduce medical expenditure. The generic drugs have the same efficacy as the branded drugs, but with cheaper price. Hence, the market need for generic drugs is increased and will be on high growth rate in the future. The development of Taiwan generic pharmaceutical companies has been limited due to the small market scale and the heavy price control of the National Health Insurance Administration (NHIA). This study used the secondary data analysis to discuss the business strategy of TEVA. Simultaneously, by interviewing the industrial experts, the study summarized the current issues and the future opportunities that the domestic pharmaceutical manufacturers in Taiwan are facing. The research points out that Internationalization, M&A strategy, and development of high value generics could be the proper ways of strategies for domestic manufacturers in Taiwan. China government is implementing conformance assessment to ensure the generics’ quality is same as branded products, hence the China market will be reformed and Taiwan pharmaceutical manufacturers has opportunities to secure further grow in China market and becoming a regional player in Asia. In the past, there are too many Pharmaceutical manufacturers in Taiwan, continuous price cutting by NHIA, and the implementation of PIC/S GMP, smaller manufacturers will be forced out the market. For the remaining companies, merge is the necessary operation strategy, in order to growth with economic scale to compete with international manufacturers in the future. In the end, two domestic companies which developing niche products were discussed, both of them have potential in domestic and international market. Their products are featured with high value and less competitors in the drug market. In conclusion, domestic generic pharmaceutical manufacturers should develop own niche products to get rid of price competition in the market
|
|---|
